Global Adoptive Cellular Immunotherapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Date: June 24, 2019
Pages: 139
Price:
US$ 3,480.00
License [?]:
Publisher: GlobalInfoResearch
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GCAF9882C32EN
Leaflet:

Download PDF Leaflet

Global Adoptive Cellular Immunotherapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity.

SCOPE OF THE REPORT:

The global Adoptive Cellular Immunotherapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Adoptive Cellular Immunotherapy.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Adoptive Cellular Immunotherapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Adoptive Cellular Immunotherapy market by product type and applications/end industries.

Market Segment by Companies, this report covers
  • Amgen Inc
  • Autolus Therapeutics Plc
  • Beijing Immunochina Medical Science & Technology Co Ltd
  • Bellicum Pharmaceuticals Inc
  • Bristol-Myers Squibb Co
  • bluebird bio Inc
  • CARsgen Therapeutics Ltd
  • Celgene Corp
  • Cell Medica Ltd
  • Cellular Biomedicine Group Inc
  • Celularity Inc
  • Celyad SA
  • Daiichi Sankyo Co Ltd
  • Fosun Pharmaceutical AG
  • Gilead Sciences Inc
  • Guangzhou Anjie Biomedical Technology Co Ltd
  • Hangzhou Converd Co Ltd
  • Hebei Senlang Biotechnology Inc Ltd
  • HRAIN Biotechnology Co Ltd
  • Juno Therapeutics Inc
  • Kite Pharma Inc
  • Nanjing Legend Biotech Co Ltd
  • NantKwest Inc
  • Nkarta Inc
  • Novartis AG
  • Ono Pharmaceutical Co Ltd
  • Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
  • Sorrento Therapeutics Inc
  • Takara Bio Inc
Market Segment by Regions, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
  • TIL
  • LAK
  • CAR-T
  • TCR-T
  • CIK
  • NK
  • DC
  • Other
Market Segment by Applications, can be divided into
  • Hospital
  • Cancer Hospital
  • Centers for Disease Control and Prevention
  • Rehabilitation Center
  • Other
1 ADOPTIVE CELLULAR IMMUNOTHERAPY MARKET OVERVIEW

1.1 Product Overview and Scope of Adoptive Cellular Immunotherapy
1.2 Classification of Adoptive Cellular Immunotherapy by Types
  1.2.1 Global Adoptive Cellular Immunotherapy Revenue Comparison by Types (2019-2024)
  1.2.2 Global Adoptive Cellular Immunotherapy Revenue Market Share by Types in 2018
  1.2.3 TIL
  1.2.4 LAK
  1.2.5 CAR-T
  1.2.6 TCR-T
  1.2.7 CIK
  1.2.8 NK
  1.2.9 DC
  1.2.10 Other
1.3 Global Adoptive Cellular Immunotherapy Market by Application
  1.3.1 Global Adoptive Cellular Immunotherapy Market Size and Market Share Comparison by Applications (2014-2024)
  1.3.2 Hospital
  1.3.3 Cancer Hospital
  1.3.4 Centers for Disease Control and Prevention
  1.3.5 Rehabilitation Center
  1.3.6 Other
1.4 Global Adoptive Cellular Immunotherapy Market by Regions
  1.4.1 Global Adoptive Cellular Immunotherapy Market Size (Million USD) Comparison by Regions (2014-2024)
  1.4.1 North America (USA, Canada and Mexico) Adoptive Cellular Immunotherapy Status and Prospect (2014-2024)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Adoptive Cellular Immunotherapy Status and Prospect (2014-2024)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Adoptive Cellular Immunotherapy Status and Prospect (2014-2024)
  1.4.4 South America (Brazil, Argentina, Colombia) Adoptive Cellular Immunotherapy Status and Prospect (2014-2024)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Adoptive Cellular Immunotherapy Status and Prospect (2014-2024)
1.5 Global Market Size of Adoptive Cellular Immunotherapy (2014-2024)

2 MANUFACTURERS PROFILES

2.1 Amgen Inc
  2.1.1 Business Overview
  2.1.2 Adoptive Cellular Immunotherapy Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Amgen Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 Autolus Therapeutics Plc
  2.2.1 Business Overview
  2.2.2 Adoptive Cellular Immunotherapy Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 Beijing Immunochina Medical Science & Technology Co Ltd
  2.3.1 Business Overview
  2.3.2 Adoptive Cellular Immunotherapy Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bellicum Pharmaceuticals Inc
  2.4.1 Business Overview
  2.4.2 Adoptive Cellular Immunotherapy Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bristol-Myers Squibb Co
  2.5.1 Business Overview
  2.5.2 Adoptive Cellular Immunotherapy Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 bluebird bio Inc
  2.6.1 Business Overview
  2.6.2 Adoptive Cellular Immunotherapy Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 bluebird bio Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.7 CARsgen Therapeutics Ltd
  2.7.1 Business Overview
  2.7.2 Adoptive Cellular Immunotherapy Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.8 Celgene Corp
  2.8.1 Business Overview
  2.8.2 Adoptive Cellular Immunotherapy Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Celgene Corp Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.9 Cell Medica Ltd
  2.9.1 Business Overview
  2.9.2 Adoptive Cellular Immunotherapy Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.10 Cellular Biomedicine Group Inc
  2.10.1 Business Overview
  2.10.2 Adoptive Cellular Immunotherapy Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.11 Celularity Inc
  2.11.1 Business Overview
  2.11.2 Adoptive Cellular Immunotherapy Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Celularity Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.12 Celyad SA
  2.12.1 Business Overview
  2.12.2 Adoptive Cellular Immunotherapy Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 Celyad SA Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.13 Daiichi Sankyo Co Ltd
  2.13.1 Business Overview
  2.13.2 Adoptive Cellular Immunotherapy Type and Applications
    2.13.2.1 Product A
    2.13.2.2 Product B
  2.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.14 Fosun Pharmaceutical AG
  2.14.1 Business Overview
  2.14.2 Adoptive Cellular Immunotherapy Type and Applications
    2.14.2.1 Product A
    2.14.2.2 Product B
  2.14.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.15 Gilead Sciences Inc
  2.15.1 Business Overview
  2.15.2 Adoptive Cellular Immunotherapy Type and Applications
    2.15.2.1 Product A
    2.15.2.2 Product B
  2.15.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.16 Guangzhou Anjie Biomedical Technology Co Ltd
  2.16.1 Business Overview
  2.16.2 Adoptive Cellular Immunotherapy Type and Applications
    2.16.2.1 Product A
    2.16.2.2 Product B
  2.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.17 Hangzhou Converd Co Ltd
  2.17.1 Business Overview
  2.17.2 Adoptive Cellular Immunotherapy Type and Applications
    2.17.2.1 Product A
    2.17.2.2 Product B
  2.17.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.18 Hebei Senlang Biotechnology Inc Ltd
  2.18.1 Business Overview
  2.18.2 Adoptive Cellular Immunotherapy Type and Applications
    2.18.2.1 Product A
    2.18.2.2 Product B
  2.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.19 HRAIN Biotechnology Co Ltd
  2.19.1 Business Overview
  2.19.2 Adoptive Cellular Immunotherapy Type and Applications
    2.19.2.1 Product A
    2.19.2.2 Product B
  2.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.20 Juno Therapeutics Inc
  2.20.1 Business Overview
  2.20.2 Adoptive Cellular Immunotherapy Type and Applications
    2.20.2.1 Product A
    2.20.2.2 Product B
  2.20.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.21 Kite Pharma Inc
  2.21.1 Business Overview
  2.2.2 Adoptive Cellular Immunotherapy Type and Applications
    2.21.2.1 Product A
    2.21.2.2 Product B
  2.21.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.22 Nanjing Legend Biotech Co Ltd
  2.22.1 Business Overview
  2.22.2 Adoptive Cellular Immunotherapy Type and Applications
    2.22.2.1 Product A
    2.22.2.2 Product B
  2.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.23 NantKwest Inc
  2.23.1 Business Overview
  2.23.2 Adoptive Cellular Immunotherapy Type and Applications
    2.23.2.1 Product A
    2.23.2.2 Product B
  2.23.3 NantKwest Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.24 Nkarta Inc
  2.24.1 Business Overview
  2.24.2 Adoptive Cellular Immunotherapy Type and Applications
    2.24.2.1 Product A
    2.24.2.2 Product B
  2.24.3 Nkarta Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.25 Novartis AG
  2.25.1 Business Overview
  2.25.2 Adoptive Cellular Immunotherapy Type and Applications
    2.25.2.1 Product A
    2.25.2.2 Product B
  2.25.3 Novartis AG Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.26 Ono Pharmaceutical Co Ltd
  2.26.1 Business Overview
  2.26.2 Adoptive Cellular Immunotherapy Type and Applications
    2.26.2.1 Product A
    2.26.2.2 Product B
  2.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
  2.27.1 Business Overview
  2.27.2 Adoptive Cellular Immunotherapy Type and Applications
    2.27.2.1 Product A
    2.27.2.2 Product B
  2.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.28 Sorrento Therapeutics Inc
  2.28.1 Business Overview
  2.28.2 Adoptive Cellular Immunotherapy Type and Applications
    2.28.2.1 Product A
    2.28.2.2 Product B
  2.28.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.29 Takara Bio Inc
  2.29.1 Business Overview
  2.29.2 Adoptive Cellular Immunotherapy Type and Applications
    2.29.2.1 Product A
    2.29.2.2 Product B
  2.29.3 Takara Bio Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)

3 GLOBAL ADOPTIVE CELLULAR IMMUNOTHERAPY MARKET COMPETITION, BY PLAYERS

3.1 Global Adoptive Cellular Immunotherapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
  3.2.1 Top 5 Adoptive Cellular Immunotherapy Players Market Share
  3.2.2 Top 10 Adoptive Cellular Immunotherapy Players Market Share
3.3 Market Competition Trend

4 GLOBAL ADOPTIVE CELLULAR IMMUNOTHERAPY MARKET SIZE BY REGIONS

4.1 Global Adoptive Cellular Immunotherapy Revenue and Market Share by Regions
4.2 North America Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
4.3 Europe Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
4.5 South America Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)

5 NORTH AMERICA ADOPTIVE CELLULAR IMMUNOTHERAPY REVENUE BY COUNTRIES

5.1 North America Adoptive Cellular Immunotherapy Revenue by Countries (2014-2019)
5.2 USA Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
5.3 Canada Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)

6 EUROPE ADOPTIVE CELLULAR IMMUNOTHERAPY REVENUE BY COUNTRIES

6.1 Europe Adoptive Cellular Immunotherapy Revenue by Countries (2014-2019)
6.2 Germany Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
6.3 UK Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
6.4 France Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
6.5 Russia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
6.6 Italy Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)

7 ASIA-PACIFIC ADOPTIVE CELLULAR IMMUNOTHERAPY REVENUE BY COUNTRIES

7.1 Asia-Pacific Adoptive Cellular Immunotherapy Revenue by Countries (2014-2019)
7.2 China Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
7.3 Japan Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
7.4 Korea Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
7.5 India Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)

8 SOUTH AMERICA ADOPTIVE CELLULAR IMMUNOTHERAPY REVENUE BY COUNTRIES

8.1 South America Adoptive Cellular Immunotherapy Revenue by Countries (2014-2019)
8.2 Brazil Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)

9 MIDDLE EAST AND AFRICA REVENUE ADOPTIVE CELLULAR IMMUNOTHERAPY BY COUNTRIES

9.1 Middle East and Africa Adoptive Cellular Immunotherapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
9.3 UAE Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)

10 GLOBAL ADOPTIVE CELLULAR IMMUNOTHERAPY MARKET SEGMENT BY TYPE

10.1 Global Adoptive Cellular Immunotherapy Revenue and Market Share by Type (2014-2019)
10.2 Global Adoptive Cellular Immunotherapy Market Forecast by Type (2019-2024)
10.3 TIL Revenue Growth Rate (2014-2024)
10.4 LAK Revenue Growth Rate (2014-2024)
10.5 CAR-T Revenue Growth Rate (2014-2024)
10.6 TCR-T Revenue Growth Rate (2014-2024)
10.7 CIK Revenue Growth Rate (2014-2024)
10.8 NK Revenue Growth Rate (2014-2024)
10.9 DC Revenue Growth Rate (2014-2024)
10.10 Other Revenue Growth Rate (2014-2024)

11 GLOBAL ADOPTIVE CELLULAR IMMUNOTHERAPY MARKET SEGMENT BY APPLICATION

11.1 Global Adoptive Cellular Immunotherapy Revenue Market Share by Application (2014-2019)
11.2 Adoptive Cellular Immunotherapy Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Cancer Hospital Revenue Growth (2014-2019)
11.5 Centers for Disease Control and Prevention Revenue Growth (2014-2019)
11.6 Rehabilitation Center Revenue Growth (2014-2019)
11.7 Other Revenue Growth (2014-2019)

12 GLOBAL ADOPTIVE CELLULAR IMMUNOTHERAPY MARKET SIZE FORECAST (2019-2024)

12.1 Global Adoptive Cellular Immunotherapy Market Size Forecast (2019-2024)
12.2 Global Adoptive Cellular Immunotherapy Market Forecast by Regions (2019-2024)
12.3 North America Adoptive Cellular Immunotherapy Revenue Market Forecast (2019-2024)
12.4 Europe Adoptive Cellular Immunotherapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Adoptive Cellular Immunotherapy Revenue Market Forecast (2019-2024)
12.6 South America Adoptive Cellular Immunotherapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Adoptive Cellular Immunotherapy Revenue Market Forecast (2019-2024)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES

Figure Adoptive Cellular Immunotherapy Picture
Table Product Specifications of Adoptive Cellular Immunotherapy
Table Global Adoptive Cellular Immunotherapy and Revenue (Million USD) Market Split by Product Type
Figure Global Adoptive Cellular Immunotherapy Revenue Market Share by Types in 2018
Figure TIL Picture
Figure LAK Picture
Figure CAR-T Picture
Figure TCR-T Picture
Figure CIK Picture
Figure NK Picture
Figure DC Picture
Figure Other Picture
Table Global Adoptive Cellular Immunotherapy Revenue (Million USD) by Application (2014-2024)
Figure Adoptive Cellular Immunotherapy Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Cancer Hospital Picture
Figure Centers for Disease Control and Prevention Picture
Figure Rehabilitation Center Picture
Figure Other Picture
Table Global Market Adoptive Cellular Immunotherapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Adoptive Cellular Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Adoptive Cellular Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Adoptive Cellular Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Adoptive Cellular Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Adoptive Cellular Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Adoptive Cellular Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Table Amgen Inc Basic Information, Manufacturing Base and Competitors
Table Amgen Inc Adoptive Cellular Immunotherapy Type and Applications
Table Amgen Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Autolus Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Type and Applications
Table Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Beijing Immunochina Medical Science & Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Bellicum Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Type and Applications
Table Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Co Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Type and Applications
Table Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table bluebird bio Inc Basic Information, Manufacturing Base and Competitors
Table bluebird bio Inc Adoptive Cellular Immunotherapy Type and Applications
Table bluebird bio Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table CARsgen Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Type and Applications
Table CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Corp Basic Information, Manufacturing Base and Competitors
Table Celgene Corp Adoptive Cellular Immunotherapy Type and Applications
Table Celgene Corp Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Cell Medica Ltd Basic Information, Manufacturing Base and Competitors
Table Cell Medica Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Cell Medica Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Cellular Biomedicine Group Inc Basic Information, Manufacturing Base and Competitors
Table Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Type and Applications
Table Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Celularity Inc Basic Information, Manufacturing Base and Competitors
Table Celularity Inc Adoptive Cellular Immunotherapy Type and Applications
Table Celularity Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Celyad SA Basic Information, Manufacturing Base and Competitors
Table Celyad SA Adoptive Cellular Immunotherapy Type and Applications
Table Celyad SA Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Fosun Pharmaceutical AG Basic Information, Manufacturing Base and Competitors
Table Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Type and Applications
Table Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Inc Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Inc Adoptive Cellular Immunotherapy Type and Applications
Table Gilead Sciences Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Guangzhou Anjie Biomedical Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Hangzhou Converd Co Ltd Basic Information, Manufacturing Base and Competitors
Table Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Hebei Senlang Biotechnology Inc Ltd Basic Information, Manufacturing Base and Competitors
Table Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table HRAIN Biotechnology Co Ltd Basic Information, Manufacturing Base and Competitors
Table HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Juno Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table Juno Therapeutics Inc Adoptive Cellular Immunotherapy Type and Applications
Table Juno Therapeutics Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Kite Pharma Inc Basic Information, Manufacturing Base and Competitors
Table Kite Pharma Inc Adoptive Cellular Immunotherapy Type and Applications
Table Kite Pharma Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Nanjing Legend Biotech Co Ltd Basic Information, Manufacturing Base and Competitors
Table Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table NantKwest Inc Basic Information, Manufacturing Base and Competitors
Table NantKwest Inc Adoptive Cellular Immunotherapy Type and Applications
Table NantKwest Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Nkarta Inc Basic Information, Manufacturing Base and Competitors
Table Nkarta Inc Adoptive Cellular Immunotherapy Type and Applications
Table Nkarta Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Adoptive Cellular Immunotherapy Type and Applications
Table Novartis AG Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Ono Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Sorrento Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Type and Applications
Table Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Takara Bio Inc Basic Information, Manufacturing Base and Competitors
Table Takara Bio Inc Adoptive Cellular Immunotherapy Type and Applications
Table Takara Bio Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global Adoptive Cellular Immunotherapy Revenue (Million USD) by Players (2014-2019)
Table Global Adoptive Cellular Immunotherapy Revenue Share by Players (2014-2019)
Figure Global Adoptive Cellular Immunotherapy Revenue Share by Players in 2017
Figure Global Adoptive Cellular Immunotherapy Revenue Share by Players in 2018
Figure Global Top 5 Players Adoptive Cellular Immunotherapy Revenue Market Share in 2018
Figure Global Top 10 Players Adoptive Cellular Immunotherapy Revenue Market Share in 2018
Figure Global Adoptive Cellular Immunotherapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Adoptive Cellular Immunotherapy Revenue (Million USD) by Regions (2014-2019)
Table Global Adoptive Cellular Immunotherapy Revenue Market Share by Regions (2014-2019)
Figure Global Adoptive Cellular Immunotherapy Revenue Market Share by Regions (2014-2019)
Figure Global Adoptive Cellular Immunotherapy Revenue Market Share by Regions in 2018
Figure North America Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Europe Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure South America Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Table North America Adoptive Cellular Immunotherapy Revenue by Countries (2014-2019)
Table North America Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure North America Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure North America Adoptive Cellular Immunotherapy Revenue Market Share by Countries in 2018
Figure USA Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Canada Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Mexico Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Table Europe Adoptive Cellular Immunotherapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Europe Adoptive Cellular Immunotherapy Revenue Market Share by Countries in 2018
Figure Germany Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure UK Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure France Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Russia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Italy Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Adoptive Cellular Immunotherapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Adoptive Cellular Immunotherapy Revenue Market Share by Countries in 2018
Figure China Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Japan Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Korea Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure India Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Table South America Adoptive Cellular Immunotherapy Revenue by Countries (2014-2019)
Table South America Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure South America Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure South America Adoptive Cellular Immunotherapy Revenue Market Share by Countries in 2018
Figure Brazil Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Argentina Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Colombia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Adoptive Cellular Immunotherapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Adoptive Cellular Immunotherapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure UAE Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Egypt Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure South Africa Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Table Global Adoptive Cellular Immunotherapy Revenue (Million USD) by Type (2014-2019)
Table Global Adoptive Cellular Immunotherapy Revenue Share by Type (2014-2019)
Figure Global Adoptive Cellular Immunotherapy Revenue Share by Type (2014-2019)
Figure Global Adoptive Cellular Immunotherapy Revenue Share by Type in 2018
Table Global Adoptive Cellular Immunotherapy Revenue Forecast by Type (2019-2024)
Figure Global Adoptive Cellular Immunotherapy Market Share Forecast by Type (2019-2024)
Figure Global TIL Revenue Growth Rate (2014-2019)
Figure Global LAK Revenue Growth Rate (2014-2019)
Figure Global CAR-T Revenue Growth Rate (2014-2019)
Figure Global TCR-T Revenue Growth Rate (2014-2019)
Figure Global CIK Revenue Growth Rate (2014-2019)
Figure Global NK Revenue Growth Rate (2014-2019)
Figure Global DC Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Adoptive Cellular Immunotherapy Revenue by Application (2014-2019)
Table Global Adoptive Cellular Immunotherapy Revenue Share by Application (2014-2019)
Figure Global Adoptive Cellular Immunotherapy Revenue Share by Application (2014-2019)
Figure Global Adoptive Cellular Immunotherapy Revenue Share by Application in 2018
Table Global Adoptive Cellular Immunotherapy Revenue Forecast by Application (2019-2024)
Figure Global Adoptive Cellular Immunotherapy Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Cancer Hospital Revenue Growth Rate (2014-2019)
Figure Global Centers for Disease Control and Prevention Revenue Growth Rate (2014-2019)
Figure Global Rehabilitation Center Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Adoptive Cellular Immunotherapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Adoptive Cellular Immunotherapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Adoptive Cellular Immunotherapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Adoptive Cellular Immunotherapy Revenue Market Forecast (2019-2024)
Figure Europe Adoptive Cellular Immunotherapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Adoptive Cellular Immunotherapy Revenue Market Forecast (2019-2024)
Figure South America Adoptive Cellular Immunotherapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Adoptive Cellular Immunotherapy Revenue Market Forecast (2019-2024)
Skip to top


Ask Your Question

Global Adoptive Cellular Immunotherapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: